|ZFIN ID: ZDB-PUB-140513-147|
Developmental processes regulated by the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) pathway: Highlights from animal studies
Eisa-Beygi, S., Ekker, M., Moon, T.W., Macdonald, R.L., Wen, X.Y.
|Source:||Reproductive toxicology (Elmsford, N.Y.) 46C: 115-120 (Review)|
|Registered Authors:||Eisa-Beygi, Shahram, Ekker, Marc|
|Keywords:||Cholesterol, Development, HMGCR, Prenylation, Statins, Teratogenesis, Toxicity|
|PubMed:||24732207 Full text @ Reprod. Toxicol.|
Eisa-Beygi, S., Ekker, M., Moon, T.W., Macdonald, R.L., Wen, X.Y. (2014) Developmental processes regulated by the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) pathway: Highlights from animal studies. Reproductive toxicology (Elmsford, N.Y.). 46C:115-120.
ABSTRACTThe 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) is the rate-limiting enzyme in the biosynthesis of cholesterol and isoprenoids, which are substrates required for post-translational modification of signalling proteins that can potentially regulate various aspects of embryonic development. The HMGCR transcripts are detectable during early embryogenesis in both invertebrates and vertebrates, which suggests a conserved developmental requirement for mevalonate derivatives. Consistently, recent animal and in vitro studies have yielded valuable insights into potential morphogenic parameters that are modulated by HMGCR activity. These developmental end-points include brain and craniofacial morphogenesis, PGC migration and survival, myocardial epithelial migration and fusion, EC migration and survival, and vascular stabilization. By providing a synthesis of these studies, we hope that this review will highlight the need to comprehensively examine the entire suite of developmental processes regulated by HMGCR.
ADDITIONAL INFORMATION No data available